dc.contributor.author | CHRISTIANTY, Fransiska Maria | |
dc.contributor.author | DIANASARI, Dewi | |
dc.contributor.author | HOLIDAH, Diana | |
dc.contributor.author | BASYRAHIL, Nargiss Lukman Hakim Salim | |
dc.contributor.author | RIZKI, Putri Efina Tsamrotul | |
dc.contributor.author | SAPUTRI, Laili Nurul Didik | |
dc.contributor.author | JANI, Yahya | |
dc.contributor.author | ZALIZAR, Lili | |
dc.date.accessioned | 2020-09-30T03:18:17Z | |
dc.date.available | 2020-09-30T03:18:17Z | |
dc.date.issued | 2020-05-01 | |
dc.identifier.uri | http://repository.unej.ac.id/handle/123456789/101056 | |
dc.description.abstract | Liver is one of the primary and largest metabolic organs in the body. The function of the liver can be disturbed and
damaged by paracetamol and liver damage can be prevented with papaya (Carica papaya L.). The purpose of this
study was to know the effects of C. papaya juice on plasma AST/ALT level and liver histopathology in
paracetamol-induced mice. Amount 25 Balb–C mice (Mus musculus) were divided into five treatment groups,
there were normal, negative control, papaya juice dose (200, 400, 600) mg kg
groups. The treatment was
carried out for 7 d and then all mice (without normal groups) was induced by paracetamol. On the 8
–1
–1
bw
d, blood was
collected and all mice were sacrificed. The materials used in this study include C. papaya juice, CMC Na,
paracetamol, AST and ALT reagents, Hematoxylin-Eosin and used Experimental Laboratory methods. One Way
ANOVA and Kruskal Wallis with a confidence level of 95 % and followed by a post hoc test (LSD) to determine
differences between groups. Showed that pretreatment with papaya juice could prevent liver damage and inhibit
the increase of plasma AST/ALT level and papaya juice dose 600 mg kg
th
had significant effects on plasma
AST/ALT level and liver histopathology in paracetamol-induced mice. Carica papaya L. juice can be used as a
hepatoprotective agent. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Annals of Tropical Medicine & Public Health, May 2020 Vol. 23 Issue 8 | en_US |
dc.subject | Advantage papaya for health | en_US |
dc.subject | AST/ALT | en_US |
dc.subject | hepatoprotective agent | en_US |
dc.subject | in vivo | en_US |
dc.subject | manja roenigk score | en_US |
dc.title | The Effects of Carica papaya L. Juice on Plasma Aspartate Transaminase/Alanine Transaminase Level and Liver Histopathology in Paracetamol–Induced Mice | en_US |
dc.type | Article | en_US |
dc.identifier.kodeprodi | kodeprodi2210101#Farmasi | |
dc.identifier.nidn | NIDN0006048405 | |
dc.identifier.nidn | NIDN0008128701 | |
dc.identifier.nidn | NIDN0021127801 | |